Is Danaher Corporation (DHR) a Buy? The Stock Reaches 52-Week High Today

November 21, 2017 - By Kurt Siggers

Investors sentiment increased to 1.41 in 2017 Q2. Its up 0.35, from 1.06 in 2017Q1. It improved, as 42 investors sold Danaher Corporation shares while 311 reduced holdings. 74 funds opened positions while 423 raised stakes. 508.92 million shares or 0.25% less from 510.21 million shares in 2017Q1 were reported.
Dubuque Bancorporation & invested 0.01% of its portfolio in Danaher Corporation (NYSE:DHR). First Merchants owns 0.67% invested in Danaher Corporation (NYSE:DHR) for 28,815 shares. New Mexico Educational Retirement Board invested 0.22% of its portfolio in Danaher Corporation (NYSE:DHR). Private Advisor Gru Limited Com reported 18,917 shares. Johnson Counsel holds 1.37% or 582,455 shares in its portfolio. Carroll Associates Incorporated accumulated 853 shares. Sei Com holds 0.12% or 371,106 shares. Boothbay Fund Mgmt Limited holds 0.08% or 4,532 shares. Kornitzer Management Inc Ks reported 380,885 shares or 0.56% of all its holdings. Brown Brothers Harriman & Co holds 0.01% of its portfolio in Danaher Corporation (NYSE:DHR) for 17,936 shares. Lakeview Cap Prtnrs Ltd Liability Corp has 2,604 shares. Swiss Commercial Bank invested in 0.26% or 2.64M shares. Cibc Asset Mngmt Inc accumulated 60,592 shares. Pictet North America has 0.05% invested in Danaher Corporation (NYSE:DHR). Jlb And Assocs Inc invested in 0.48% or 22,207 shares.

The stock of Danaher Corporation (NYSE:DHR) hit a new 52-week high and has $99.66 target or 6.00 % above today’s $94.02 share price. The 8 months bullish chart indicates low risk for the $65.40B company. The 1-year high was reported on Nov, 21 by If the $99.66 price target is reached, the company will be worth $3.92B more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock.

About 211,406 shares traded. Danaher Corporation (NYSE:DHR) has risen 10.62% since November 21, 2016 and is uptrending. It has underperformed by 6.08% the S&P500.

Wall Street await Danaher Corporation (NYSE:DHR) to release earnings on January, 30. Analysts forecast earnings per share of $1.15, up exactly $0.10 or 9.52 % from 2014’s $1.05 EPS. The expected DHR’s profit could reach $799.94M giving the stock 20.41 P/E in the case that $1.15 earnings per share is reported. After posting $1.00 EPS for the previous quarter, Danaher Corporation’s analysts now forecast 15.00 % EPS growth.

Danaher Corporation (NYSE:DHR) Ratings Coverage

Among 18 analysts covering Danaher Corporation (NYSE:DHR), 13 have Buy rating, 0 Sell and 5 Hold. Therefore 72% are positive. Danaher Corporation has $120 highest and $83.0 lowest target. $97.58’s average target is 3.79% above currents $94.02 stock price. Danaher Corporation had 69 analyst reports since July 28, 2015 according to SRatingsIntel. The firm has “Outperform” rating by Leerink Swann given on Wednesday, September 30. On Friday, October 23 the stock rating was maintained by Barclays Capital with “Overweight”. On Friday, July 21 the stock rating was maintained by Citigroup with “Buy”. The stock of Danaher Corporation (NYSE:DHR) earned “Overweight” rating by Barclays Capital on Monday, July 11. The firm has “Hold” rating given on Tuesday, September 26 by Goldman Sachs. Robert W. Baird maintained Danaher Corporation (NYSE:DHR) on Friday, October 20 with “Outperform” rating. Cowen & Co maintained it with “Buy” rating and $100.0 target in Thursday, October 19 report. The firm has “Buy” rating by Jefferies given on Thursday, June 29. The firm earned “Buy” rating on Friday, February 24 by Citigroup. As per Wednesday, September 7, the company rating was maintained by Barclays Capital.

More notable recent Danaher Corporation (NYSE:DHR) news were published by: which released: “Sales Growth Penalizes Danaher Corporation (DHR) Rating” on October 31, 2017, also with their article: “Shares of Danaher Corporation (DHR) Raised to Buy From a Hold” published on November 07, 2017, published: “Analytics for Earnings Momentum Drive Upgrade of Danaher Corporation (DHR) to Buy” on November 14, 2017. More interesting news about Danaher Corporation (NYSE:DHR) were released by: and their article: “Time to Get Greedy or Fearful With Danaher Corporation’s Stock?” published on November 15, 2017 as well as‘s news article titled: “Lackluster Earnings Visibility Hurts Danaher Corporation (DHR) Rating” with publication date: October 24, 2017.

Danaher Corporation designs, makes and markets professional, medical, industrial and commercial services and products. The company has market cap of $65.40 billion. The Firm operates through four divisions: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification. It has a 28.02 P/E ratio.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.